Hemma Wellness
Member LoginGet Started
Back to Hemma
Hemma Wellness

Medications SafetyInformation

This document provides important safety information about certain medications that may be prescribed through Hemma Wellness Group LLC’s telehealth services. It is intended for educational purposes only and does not replace medical advice from your licensed healthcare provider.

Effective: October 2025

Current as of: October 2025

Important Safety Notice

This document provides important safety information about certain medications that may be prescribed through Hemma Wellness Group LLC’s telehealth services. It is intended for educational purposes only and does not replace medical advice from your licensed healthcare provider.

If you are prescribed a medication, you will also receive the official FDA Prescribing Information and/or Medication Guide. Always read those materials carefully and discuss any questions with your provider.

What This Page Covers

This page summarizes the reviewed safety information included in the attached medications document.

  1. General disclaimer and emergency guidance
  2. GLP-1 medication options, boxed warning, and side effects
  3. Compounded GLP-1 safety disclosures
  4. Hormone therapy safety considerations
  5. Supplement disclosures
  6. Patient responsibilities for safer use

Full document

General Disclaimer

  • Hemma Wellness Group LLC does not manufacture medications.
  • All prescription decisions are made by independent, licensed healthcare providers.
  • Information on this page is based on FDA-approved prescribing information and other publicly available safety data.
  • If you experience a medical emergency, call 911 immediately.
  • Report side effects to your provider, or directly --to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

GLP-1 Medications

FDA-Approved Options

  • Wegovy® (semaglutide)
  • Ozempic® (semaglutide)
  • Zepbound® (tirzepatide)
  • Mounjaro® (tirzepatide)
  • Saxenda® (liraglutide)

Boxed Warning: GLP-1 medications may increase the risk of thyroid C-cell tumors. Do not use if you or your family have a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Serious Risks May Include

  • Pancreatitis
  • Gallbladder disease
  • Severe gastrointestinal side effects
  • Kidney injury related to dehydration
  • Suicidal thoughts or behavior

Common Side Effects

  • Nausea
  • Vomiting
  • Diarrhea
  • Constipation
  • Abdominal pain

The information in this document is not comprehensive. For detailed safety information, please see the full Prescribing Information for each medication.

Compounded GLP-1 Options

  • In some cases, licensed providers may prescribe compounded semaglutide or tirzepatide.
  • Important Note: Compounded medications are not FDA-approved. They are prepared by state-licensed compounding pharmacies when commercially available alternatives are not suitable or accessible.
  • Safety, efficacy, and manufacturing standards are not reviewed by the FDA.

Hormone Therapy (HRT)

Hormone therapies (including estrogen, progesterone) may be prescribed for menopausal or midlife wellness support.

Important Safety Considerations

  • Increased risk of blood clots, stroke, or heart disease in some patients
  • Not suitable for patients with certain cancers (such as breast or uterine cancer)
  • Possible mood changes, acne, or hair growth with some formulations

Always discuss personal risks with your provider before starting hormone therapy.

Supplements

Hemma Wellness may also offer dietary supplements.

  • Supplements are regulated differently than prescription medications.

Patient Responsibilities

To maximize safety, you must:

  • Provide accurate and complete health history during your intake.
Need more help

Contact Hemma for general questions, and discuss medication-specific risks or side effects with your licensed healthcare provider.

Contact UsBegin My Evaluation